306 related articles for article (PubMed ID: 18164694)
1. CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
Aguiar LM; Macêdo DS; Vasconcelos SM; Oliveira AA; de Sousa FC; Viana GS
Brain Res; 2008 Jan; 1191():192-9. PubMed ID: 18164694
[TBL] [Abstract][Full Text] [Related]
2. CSC counteracts l-DOPA-induced overactivity of the corticostriatal synaptic ultrastructure and function in 6-OHDA-lesioned rats.
Huang YX; Luo WF; Li D; Hu WD; Liu CF
Brain Res; 2011 Feb; 1376():113-21. PubMed ID: 21195062
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats.
Aguiar LM; Nobre HV; Macêdo DS; Oliveira AA; Freitas RM; Vasconcelos SM; Cunha GM; Sousa FC; Viana GS
Pharmacol Biochem Behav; 2006 Jul; 84(3):415-9. PubMed ID: 16844208
[TBL] [Abstract][Full Text] [Related]
4. Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.
Nobre HV; Cunha GM; de Vasconcelos LM; Magalhães HI; Oliveira Neto RN; Maia FD; de Moraes MO; Leal LK; Viana GS
Neurochem Int; 2010 Jan; 56(1):51-8. PubMed ID: 19782116
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats.
Song L; Kong M; Ma Y; Ba M; Liu Z
Brain Res; 2009 Jun; 1276():171-9. PubMed ID: 19393228
[TBL] [Abstract][Full Text] [Related]
7. Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease.
Kobylecki C; Cenci MA; Crossman AR; Ravenscroft P
J Neurochem; 2010 Jul; 114(2):499-511. PubMed ID: 20456008
[TBL] [Abstract][Full Text] [Related]
8. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
[TBL] [Abstract][Full Text] [Related]
10. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
Meshul CK; Kamel D; Moore C; Kay TS; Krentz L
Exp Neurol; 2002 May; 175(1):257-74. PubMed ID: 12009777
[TBL] [Abstract][Full Text] [Related]
11. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats.
Bové J; Marin C; Bonastre M; Tolosa E
Synapse; 2002 Dec; 46(4):251-7. PubMed ID: 12373740
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
14. The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N(G)-nitro-L-arginine methyl ester administered alone or jointly with L-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats.
Czarnecka A; Konieczny J; Lenda T; Lorenc-Koci E
Brain Res; 2015 Nov; 1625():218-37. PubMed ID: 26319690
[TBL] [Abstract][Full Text] [Related]
15. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine.
Molina-Holgado E; Dewar KM; Descarries L; Reader TA
J Pharmacol Exp Ther; 1994 Aug; 270(2):713-21. PubMed ID: 8071864
[TBL] [Abstract][Full Text] [Related]
16. Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
Gołembiowska K; Dziubina A
Neurotox Res; 2012 Feb; 21(2):222-30. PubMed ID: 21830163
[TBL] [Abstract][Full Text] [Related]
17. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.
Dupre KB; Eskow KL; Negron G; Bishop C
Brain Res; 2007 Jul; 1158():135-43. PubMed ID: 17553470
[TBL] [Abstract][Full Text] [Related]
18. Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?
Lane EL; Cheetham SC; Jenner P
Exp Neurol; 2006 Feb; 197(2):284-90. PubMed ID: 16005456
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
20. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
